Location: Home
  • search
  • go
  • Relate News
  • 10/27/2025AstraZeneca Unveils Three Major Initiatives in China
  • 10/25/2025Recent Executive Moves
  • 10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
  • 10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...
  • 10/24/2025Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...
  • 10/22/2025Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...
  • 10/22/2025China's Aging Population to Drive Trillion-Dollar Healthcare Boom, UBS...
  • 10/22/2025Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...
  • 10/22/2025Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...
  • 10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...
  • 10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation
  • 10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...
  • 10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...
  • 10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA
  • 10/21/2025Kelun-Biotech's Sacituzumab Tirumotecan Shows Strong Phase 3 Results
  • 10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer
  • 10/20/2025Sanofi Launches €1B Insulin API Manufacturing Project in Beijing
  • 10/20/2025CDE Seeks Comments on Implementation Recommendations and Chinese Tran...
  • 10/20/2025CDE Seeks Feedbacks on Draft Technical and Submission Requirements for...
  • 10/20/2025China Accelerates Nationwide Rollout of Real-Time BMI Fund Settlement
  • 10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC
  • 10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO
  • 10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
  • 10/17/2025Recent Executive Moves
  • 10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...
  • 10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
  • 10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...
  • 10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
  • 10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
  • 10/13/2025Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...
  • Page:3/371 Total number of articles:11127: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group